Michael Rosenblatt
Michael Rosenblatt
About this item
Full title
Michael Rosenblatt
Publisher
London: Nature Publishing Group UK
Journal title
Nature reviews. Drug discovery, 2016-09, Vol.15 (10), p.672-672
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Michael Rosenblatt, newly appointed Chief Medical Officer of Flagship Ventures and former Chief Medical Officer at Merck & Co., discusses his move from industry to venture capital.
Although biopharma start-up companies have to be laser-focused on translational science, this single-mindedness sometimes comes at the expense of clinical development...
Alternative Titles
Full title
Michael Rosenblatt
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1825215817
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1825215817
Other Identifiers
ISSN
1474-1776
E-ISSN
1474-1784
DOI
10.1038/nrd.2016.203
